kynurenic acid has been researched along with Insulin Resistance in 3 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study examined the diagnostic ability of tryptophan catabolites (TRYCATs) and insulin resistance (IR) parameters in women with PE." | 8.31 | Maternal Tryptophan Catabolites and Insulin Resistance Parameters in Preeclampsia. ( Al-Hakeim, HK; Jasim, ZA; Stanek, A; Zolghadri, S, 2023) |
| "Kynurenic acid (KA), an endogenous product of L-tryptophan metabolism in the kynurenine pathway, regulates adipose tissue energy homeostasis and inflammation." | 7.96 | Administration of kynurenic acid reduces hyperlipidemia-induced inflammation and insulin resistance in skeletal muscle and adipocytes. ( Abd El-Aty, AM; Ahn, SH; Hacimuftuoglu, A; Jeong, JH; Jung, TW; Kim, HC; Park, J; Shim, JH; Shin, S; Sun, JL, 2020) |
| " The present study examined the diagnostic ability of tryptophan catabolites (TRYCATs) and insulin resistance (IR) parameters in women with PE." | 4.31 | Maternal Tryptophan Catabolites and Insulin Resistance Parameters in Preeclampsia. ( Al-Hakeim, HK; Jasim, ZA; Stanek, A; Zolghadri, S, 2023) |
| "Kynurenic acid (KA), an endogenous product of L-tryptophan metabolism in the kynurenine pathway, regulates adipose tissue energy homeostasis and inflammation." | 3.96 | Administration of kynurenic acid reduces hyperlipidemia-induced inflammation and insulin resistance in skeletal muscle and adipocytes. ( Abd El-Aty, AM; Ahn, SH; Hacimuftuoglu, A; Jeong, JH; Jung, TW; Kim, HC; Park, J; Shim, JH; Shin, S; Sun, JL, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jasim, ZA | 1 |
| Al-Hakeim, HK | 1 |
| Zolghadri, S | 1 |
| Stanek, A | 1 |
| Jung, TW | 1 |
| Park, J | 1 |
| Sun, JL | 1 |
| Ahn, SH | 1 |
| Abd El-Aty, AM | 1 |
| Hacimuftuoglu, A | 1 |
| Kim, HC | 1 |
| Shim, JH | 1 |
| Shin, S | 1 |
| Jeong, JH | 1 |
| Oxenkrug, G | 1 |
| Bernstein, HG | 1 |
| Guest, PC | 1 |
| van der Hart, M | 1 |
| Roeser, J | 1 |
| Summergrad, P | 1 |
| Steiner, J | 1 |
3 other studies available for kynurenic acid and Insulin Resistance
| Article | Year |
|---|---|
Maternal Tryptophan Catabolites and Insulin Resistance Parameters in Preeclampsia.
Topics: Case-Control Studies; Female; Humans; Insulin Resistance; Kynurenic Acid; Kynurenine; Pre-Eclampsia; | 2023 |
Administration of kynurenic acid reduces hyperlipidemia-induced inflammation and insulin resistance in skeletal muscle and adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Cells, Cultured; Diet, High-Fat; Hyperlipidemias; Inflammation; I | 2020 |
Plasma xanthurenic acid in a context of insulin resistance and obesity in schizophrenia.
Topics: Case-Control Studies; Humans; Insulin Resistance; Kynurenic Acid; Kynurenine; Obesity; Schizophrenia | 2019 |